- Home
- SGMT vs ELMD Comparison
SGMT vs ELMD Comparison
Compare SGMT & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMT
- ELMD
- Stock Information
- Founded
- SGMT 2006
- ELMD 1992
- Country
- SGMT United States
- ELMD United States
- Employees
- SGMT N/A
- ELMD N/A
- Industry
- SGMT
- ELMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SGMT
- ELMD Health Care
- Exchange
- SGMT Nasdaq
- ELMD Nasdaq
- Market Cap
- SGMT 238.7M
- ELMD 206.5M
- IPO Year
- SGMT 2023
- ELMD 2010
- Fundamental
- Price
- SGMT $7.31
- ELMD $25.16
- Analyst Decision
- SGMT Strong Buy
- ELMD Strong Buy
- Analyst Count
- SGMT 7
- ELMD 2
- Target Price
- SGMT $26.57
- ELMD $35.50
- AVG Volume (30 Days)
- SGMT 480.3K
- ELMD 76.6K
- Earning Date
- SGMT 11-12-2025
- ELMD 11-11-2025
- Dividend Yield
- SGMT N/A
- ELMD N/A
- EPS Growth
- SGMT N/A
- ELMD 46.55
- EPS
- SGMT N/A
- ELMD 0.85
- Revenue
- SGMT N/A
- ELMD $64,000,000.00
- Revenue This Year
- SGMT N/A
- ELMD $14.47
- Revenue Next Year
- SGMT N/A
- ELMD $10.33
- P/E Ratio
- SGMT N/A
- ELMD $29.46
- Revenue Growth
- SGMT N/A
- ELMD 16.97
- 52 Week Low
- SGMT $1.73
- ELMD $17.73
- 52 Week High
- SGMT $11.41
- ELMD $35.56
- Technical
- Relative Strength Index (RSI)
- SGMT 52.06
- ELMD 57.07
- Support Level
- SGMT $7.11
- ELMD $23.98
- Resistance Level
- SGMT $7.66
- ELMD $25.94
- Average True Range (ATR)
- SGMT 0.40
- ELMD 0.87
- MACD
- SGMT 0.11
- ELMD -0.10
- Stochastic Oscillator
- SGMT 76.45
- ELMD 58.92
About SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.